Piper Sandler Reiterates Overweight Rating on Viking Therapeutic (VKTX)

July 7, 2026 7:52 AM

Piper Sandler analyst Biren Amin reiterated an Overweight rating and $71.00 price target on Viking Therapeutic (NASDAQ: VKTX).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found